David Pyott

Dr. David Pyott is an accomplished international pharmaceutical executive with more than 30 years of leadership and management experience with particular expertise in organizational scaling.

Most recently, Pyott served as Chairman and Chief Executive Officer of Allergan, Inc. where, over 17 years in the role, he transformed the company from a small eye care business with $1 billion in annual sales into a global specialty pharmaceutical and medical device company with 2014 annual sales of over $7 billion and more than 10,000 employees. Before that, Pyott served as Head of the Novartis Nutrition Division and served as a member of the Executive Committee of Novartis AG.

In addition to Pliant, Pyott currently serves as a member of the Board of Directors of Alnylam Pharmaceuticals and BioMarin Pharmaceutical, as Chairman of Bioniz Therapeutics, Inc., a private biotechnology company, and is a member of the Supervisory Board of Royal Philips in the Netherlands, a public diversified health technology company.

Pyott also serves as Deputy Chairman of the Governing Board of the London Business School, President of the Ophthalmology Foundation, President of the Advisory Board of the American Academy of Ophthalmology and is a Trustee of the California Institute of Technology.

Pyott holds a Diploma in International and European Law from the Europa Institute at the University of Amsterdam, an Honorary Degree in Medicine and a Master of Arts degree from the University of Edinburgh, and a Master of Business Administration degree from the London Business School.